Nvidia's 'Flawless' Results a 'Bright Green Light' to Own the Stock, Wedbush Says
Bright Green | 10-Q: Quarterly report
Bright Green's Shares Suspended From Nasdaq Capital Market
Express News | Bright Green Corp - Trading of Shares Suspended From Nasdaq After Nasdaq Cancelled Scheduled Sept 26, 2024 Delist Appeal Hearing
Express News | Bright Green Corp - Actively Exploring Various Strategic Alternatives to Unlock Long-Term Value
Express News | Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships
Bright Green Signs Letter of Intent to Supply Marijuana Extracts to Benuvia Operations; Shares Rise
Express News | Bright Green Embarks on Major Partnership With Benuvia Operations, LLC. Will Supply Pharma Expert With American Made Raw Materials From Its Industry Leading and Dea-Approved Sch I & II Drug Facility.
Bright Green To Supply DEA-Approved Cannabis Extracts And Psychedelics To FDA-Registered Pharmaceutical Company
Express News | Bright Green Signs LOI To Supply DEA-Approved Marijuana Extracts And Psychedelics To Benuvia Operations For Pharmaceutical Use, Highlighting Commitment To US Pharmaceutical Partnerships
Express News | Bright Green Embarks on Major Partnership With Benuvia Pharmaceuticals. Will Supply Pharma Expert With American Made Raw Materials From Its Industry Leading and Dea-Approved Sch I & II Drug Facility.
BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.
Bright Green | 10-Q: Q2 2024 Earnings Report
Bright Green Obtained $3.5M Funding Commitment
BRIGHT GREEN ANNOUNCES IT HAS OBTAINED A $3.5 MILLION FUNDING COMMITMENT UNDER AN EXISTING LINE OF CREDIT AND HAS ENGAGED AN INVESTMENT BANK TO SEEK A $15.0 MILLION DEBT FINANCING TO MOVE FORWARD WITH COMMERCIALIZATION.
Express News | Bright Green Announces It Has Obtained a $3.5 Million Funding Commitment Under an Existing Line of Credit and Has Engaged an Investment Bank to Seek a $15.0 Million Debt Financing to Move Forward With Commercialization.
Drugs Made In America CEO Is Bright Green Founder Lynn Stockwell
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Bright Green Insider Sold Shares Worth $359,700, According to a Recent SEC Filing
Bright Green(BGXX.US) 10% Shareholder Sells US$359.7K in Common Stock